Sandra Giercke

Increase in ampC promoter strength due to mutations and deletion of the attenuator in a clinical isolate of cefoxitin-resistant Escherichia coli as determined by RT–PCR

Dobryan M. Tracz, David A. Boyd, Louis Bryden et al. · Journal of Antimicrobial Chemotherapy · 2005 · 50 citations

Life Sciences, Genetics, Molecular Biology +17

Enhanced Surveillance of non‐O157 Verotoxin‐Producing <i>Escherichia coli </i>in Human Stool Samples from Manitoba

Laura H. Thompson, Sandra Giercke, Carole Beaudoin et al. · Canadian Journal of Infectious Diseases and Medical Microbiology · 2005 · 32 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +17

Evaluation of a New Chromogenic Agar Medium for Detection of Shiga Toxin-Producing Escherichia coli (STEC) and Relative Prevalences of O157 and Non-O157 STEC in Manitoba, Canada

John Wylie, Paul Van Caeseele, Matthew W. Gilmour et al. · Journal of Clinical Microbiology · 2012 · 29 citations · Full text

Veterinary Medicine, Food Science, Infectious Diseases +15

Comparison of polymerase chain reaction and Chlamydiazyme for the detection ofChlamydia trachomatis in clinical specimens

T. Walley Williams, Shaun Tyler, Sandra Giercke et al. · European Journal of Clinical Microbiology & Infectious Diseases · 1992 · 23 citations

Medicine, Infectious Diseases, Microbiology +13

Evaluation and validation of a monoclonal immunofluorescent reagent for direct detection of Bordetella pertussis

Patricia J. McNicol, Sandra Giercke, Mary C. Gray et al. · Journal of Clinical Microbiology · 1995 · 22 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17